Daniela Schmulevich, Zhi Geng, Sarah M. Joergensen, Nathaniel R. McLauchlan, Eric Winter, Alea Zone, Kathleen E. Bishop, Alyson Hinkle, Sara Holland, Pamela Z. Cacchione, Erin E. Fox, Benjamin S. Abella, Christopher L. Meador, Charles E. Wade, Allyson M. Hynes, Jeremy W. Cannon
{"title":"实时绩效改进优化了损伤控制复苏最佳实践的坚持:前瞻性试点观察研究的结果","authors":"Daniela Schmulevich, Zhi Geng, Sarah M. Joergensen, Nathaniel R. McLauchlan, Eric Winter, Alea Zone, Kathleen E. Bishop, Alyson Hinkle, Sara Holland, Pamela Z. Cacchione, Erin E. Fox, Benjamin S. Abella, Christopher L. Meador, Charles E. Wade, Allyson M. Hynes, Jeremy W. Cannon","doi":"10.1111/trf.17970","DOIUrl":null,"url":null,"abstract":"BackgroundMaintaining balanced blood product ratios during damage control resuscitation (DCR) is independently associated with improved survival. We hypothesized that real‐time performance improvement (RT‐PI) would increase adherence to DCR best practice.Study Design and MethodsFrom December 2020–August 2021, we prospectively used a bedside RT‐PI tool to guide DCR in severely injured patients surviving at least 30 min. RT‐PI study patients were compared to contemporary control patients at our institution and historic PROMMTT study patients. A subset of patients transfused ≥6 U red blood cells (RBC) in 6 h (MT+) was also identified. The primary endpoint was percentage time in a high ratio range (≥3:4) of plasma (PLAS):RBC and platelet (PLT):RBC over 6 h. Secondary endpoints included time to massive transfusion protocol activation, time to calcium and tranexamic acid (TXA) dosing, and cumulative 6‐h ratios.ResultsIncluded patients (<jats:italic>n</jats:italic> = 772) were 35 (24–51) years old with an Injury Severity Score of 27 (17–38) and 42% had penetrating injuries. RT‐PI (<jats:italic>n</jats:italic> = 10) patients spent 96% of the 6‐h resuscitation in a high PLAS:RBC range, no different versus CONTROL (<jats:italic>n</jats:italic> = 87) (96%) but more than PROMMTT (<jats:italic>n</jats:italic> = 675) (25%, <jats:italic>p</jats:italic> < .001). In the MT+ subgroup, optimal PLAS:RBC and PLT:RBC were maintained for the entire 6 h in RT‐PI (<jats:italic>n</jats:italic> = 4) versus PROMMTT (<jats:italic>n</jats:italic> = 391) patients for both PLAS (<jats:italic>p</jats:italic> < .001) and PLT ratios (<jats:italic>p</jats:italic> < .001). Time to TXA also improved significantly in RT‐PI versus CONTROL patients (27 min [22–31] vs. 51 min [29–98], <jats:italic>p</jats:italic> = .035).ConclusionIn this prospective study, RT‐PI was associated with optimized DCR. Multicenter validation of this novel approach to optimizing DCR implementation is warranted.","PeriodicalId":23266,"journal":{"name":"Transfusion","volume":null,"pages":null},"PeriodicalIF":2.5000,"publicationDate":"2024-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Real‐time performance improvement optimizes damage control resuscitation best practice adherence: Results of a pilot prospective observational study\",\"authors\":\"Daniela Schmulevich, Zhi Geng, Sarah M. Joergensen, Nathaniel R. McLauchlan, Eric Winter, Alea Zone, Kathleen E. Bishop, Alyson Hinkle, Sara Holland, Pamela Z. Cacchione, Erin E. Fox, Benjamin S. Abella, Christopher L. Meador, Charles E. Wade, Allyson M. Hynes, Jeremy W. Cannon\",\"doi\":\"10.1111/trf.17970\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"BackgroundMaintaining balanced blood product ratios during damage control resuscitation (DCR) is independently associated with improved survival. We hypothesized that real‐time performance improvement (RT‐PI) would increase adherence to DCR best practice.Study Design and MethodsFrom December 2020–August 2021, we prospectively used a bedside RT‐PI tool to guide DCR in severely injured patients surviving at least 30 min. RT‐PI study patients were compared to contemporary control patients at our institution and historic PROMMTT study patients. A subset of patients transfused ≥6 U red blood cells (RBC) in 6 h (MT+) was also identified. The primary endpoint was percentage time in a high ratio range (≥3:4) of plasma (PLAS):RBC and platelet (PLT):RBC over 6 h. Secondary endpoints included time to massive transfusion protocol activation, time to calcium and tranexamic acid (TXA) dosing, and cumulative 6‐h ratios.ResultsIncluded patients (<jats:italic>n</jats:italic> = 772) were 35 (24–51) years old with an Injury Severity Score of 27 (17–38) and 42% had penetrating injuries. RT‐PI (<jats:italic>n</jats:italic> = 10) patients spent 96% of the 6‐h resuscitation in a high PLAS:RBC range, no different versus CONTROL (<jats:italic>n</jats:italic> = 87) (96%) but more than PROMMTT (<jats:italic>n</jats:italic> = 675) (25%, <jats:italic>p</jats:italic> < .001). In the MT+ subgroup, optimal PLAS:RBC and PLT:RBC were maintained for the entire 6 h in RT‐PI (<jats:italic>n</jats:italic> = 4) versus PROMMTT (<jats:italic>n</jats:italic> = 391) patients for both PLAS (<jats:italic>p</jats:italic> < .001) and PLT ratios (<jats:italic>p</jats:italic> < .001). Time to TXA also improved significantly in RT‐PI versus CONTROL patients (27 min [22–31] vs. 51 min [29–98], <jats:italic>p</jats:italic> = .035).ConclusionIn this prospective study, RT‐PI was associated with optimized DCR. Multicenter validation of this novel approach to optimizing DCR implementation is warranted.\",\"PeriodicalId\":23266,\"journal\":{\"name\":\"Transfusion\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2024-07-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Transfusion\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/trf.17970\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transfusion","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/trf.17970","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
Real‐time performance improvement optimizes damage control resuscitation best practice adherence: Results of a pilot prospective observational study
BackgroundMaintaining balanced blood product ratios during damage control resuscitation (DCR) is independently associated with improved survival. We hypothesized that real‐time performance improvement (RT‐PI) would increase adherence to DCR best practice.Study Design and MethodsFrom December 2020–August 2021, we prospectively used a bedside RT‐PI tool to guide DCR in severely injured patients surviving at least 30 min. RT‐PI study patients were compared to contemporary control patients at our institution and historic PROMMTT study patients. A subset of patients transfused ≥6 U red blood cells (RBC) in 6 h (MT+) was also identified. The primary endpoint was percentage time in a high ratio range (≥3:4) of plasma (PLAS):RBC and platelet (PLT):RBC over 6 h. Secondary endpoints included time to massive transfusion protocol activation, time to calcium and tranexamic acid (TXA) dosing, and cumulative 6‐h ratios.ResultsIncluded patients (n = 772) were 35 (24–51) years old with an Injury Severity Score of 27 (17–38) and 42% had penetrating injuries. RT‐PI (n = 10) patients spent 96% of the 6‐h resuscitation in a high PLAS:RBC range, no different versus CONTROL (n = 87) (96%) but more than PROMMTT (n = 675) (25%, p < .001). In the MT+ subgroup, optimal PLAS:RBC and PLT:RBC were maintained for the entire 6 h in RT‐PI (n = 4) versus PROMMTT (n = 391) patients for both PLAS (p < .001) and PLT ratios (p < .001). Time to TXA also improved significantly in RT‐PI versus CONTROL patients (27 min [22–31] vs. 51 min [29–98], p = .035).ConclusionIn this prospective study, RT‐PI was associated with optimized DCR. Multicenter validation of this novel approach to optimizing DCR implementation is warranted.
期刊介绍:
TRANSFUSION is the foremost publication in the world for new information regarding transfusion medicine. Written by and for members of AABB and other health-care workers, TRANSFUSION reports on the latest technical advances, discusses opposing viewpoints regarding controversial issues, and presents key conference proceedings. In addition to blood banking and transfusion medicine topics, TRANSFUSION presents submissions concerning patient blood management, tissue transplantation and hematopoietic, cellular, and gene therapies.